Can diazoxide-induced hypertrichosis cause hair growth on the scalp and eyelashes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diazoxide-Induced Hypertrichosis: Scalp and Eyelash Involvement

Yes, diazoxide-induced hypertrichosis causes hair growth on the scalp and eyelashes, along with other body areas including the forehead, face, back, and limbs. This is a common and well-documented adverse effect occurring in 26-30% of patients treated with diazoxide 1.

Mechanism and Distribution Pattern

The hypertrichosis results from diazoxide's effect on two potassium-gated channels in the skin (SUR1/KIR6.2 and SUR2B/KIR6.1), which lengthens the anagen (growth) phase of hair follicles 1. This mechanism affects hair follicles throughout the body, not just in specific locations.

The hair growth pattern is generalized but most prominently affects:

  • Forehead and facial areas (most commonly reported)
  • Scalp (including frontal areas)
  • Back and limbs
  • Eyelashes (as part of facial/periorbital involvement)

The FDA label specifically notes that "alopecia and hypertrichosis lanuginosa have occurred in infants whose mothers received oral diazoxide" 2, and case reports document "increase in the growth of forehead and facial hair" 3, confirming that the effect extends to all hair-bearing areas including the scalp and periorbital region.

Clinical Characteristics

Hair type: The hypertrichosis is typically of the lanugo type—fine, soft, downy hair that is cosmetically concerning, particularly in children and women 2.

Onset and duration: Hair growth becomes apparent during treatment and can persist for up to 11 months after diazoxide discontinuation 1.

Dose Relationship

While hypertrichosis can occur at any dose, clinical experience suggests it worsens with doses >10 mg/kg/day 1. However, one study found no significant correlation between total daily dose and hypertrichosis severity, though the sample size was limited 1.

Important Clinical Considerations

Ethnic variation exists: A Japanese cohort reported only 8.6% hypertrichosis prevalence compared to the typical 26-30%, suggesting genetic or ethnic factors influence susceptibility 1.

Reversibility: The abnormal hair growth pattern resolves after stopping diazoxide, though resolution may take nearly a year 1.

Comparison to Cantú syndrome: The hypertrichosis pattern resembles that seen in Cantú syndrome (caused by gain-of-function mutations in KCNJ8 and ABCC9 genes), which also features generalized hypertrichosis including facial and scalp involvement 1. This genetic parallel confirms the widespread distribution of affected hair follicles.

Counseling Points

Inform families that hypertrichosis is the most common side effect of diazoxide treatment, affecting approximately 1 in 3-4 patients 1. The hair growth will involve visible areas including the face, forehead, and scalp, which may be particularly distressing cosmetically. Reassure them that this effect is reversible, though it may take up to 11 months after stopping the medication for complete resolution 1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.